Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) Sees Large Increase in Short Interest

Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) saw a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling 283,300 shares, a growth of 113.3% from the December 31st total of 132,800 shares. Based on an average daily trading volume, of 128,139,400 shares, the short-interest ratio is currently 0.0 days.

Therapeutic Solutions International Stock Down 33.3 %

Shares of TSOI stock traded down $0.00 on Wednesday, hitting $0.00. 3,282,685 shares of the company’s stock traded hands, compared to its average volume of 43,973,766. Therapeutic Solutions International has a one year low of $0.00 and a one year high of $0.00.

About Therapeutic Solutions International

Therapeutic Solutions International, Inc focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production.